Literature DB >> 10556219

Physiologically assessed coronary collateral flow and intracoronary growth factor concentrations in patients with 1- to 3-vessel coronary artery disease.

M Fleisch1, M Billinger, F R Eberli, A R Garachemani, B Meier, C Seiler.   

Abstract

BACKGROUND: The purpose of this study was to test the hypothesis that there is a relation between collateral flow and intracoronary concentrations of basic fibroblast growth factor (bFGF) and vascular endothelial growth factor (VEGF) and that the combined concentrations of both growth factors and the extent of coronary artery disease (CAD) play a role as covariables in such an association. METHODS AND
RESULTS: In 76 patients undergoing balloon angioplasty, a collateral flow index (CFI, no units) was determined with sensor-tipped guidewires. Simultaneously, serum concentrations of bFGF and VEGF, obtained at the aortic root from the ostium of the collateralized coronary artery (n = 76) and from the distal position of the occluded coronary artery (n = 34), were determined. There was a direct correlation between CFI and distal VEGF (r = 0.33, P = 0.05) but not bFGF concentrations. Focusing on the proximal sampling site, there was a direct correlation between CFI and both bFGF (r = 0.29, P = 0.01) and VEGF concentrations (r = 0.44, P < 0.0001). The sum of the concentrations of both growth factors was directly associated with CFI irrespective of the proximal (r = 0.51, P < 0.0001) or distal sampling site (r = 0.34, P = 0.048). There was a trend toward higher proximal VEGF concentrations in patients with higher numbers of coronary stenotic lesions (r = 0.25, P = 0.03).
CONCLUSIONS: In patients with CAD, there is an association between a directly measured index of collateral flow and intracoronary concentrations of bFGF and VEGF. This direct relation is dependent on the site of blood sampling within the coronary artery tree. The association is closest when the combined bFGF and VEGF concentrations are taken into account. In the case of VEGF, it is influenced by the degree of coronary atherosclerosis.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10556219     DOI: 10.1161/01.cir.100.19.1945

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  9 in total

1.  Vascular endothelial growth factor (VEGF) plasma concentrations in coronary artery disease.

Authors:  H F Alber; M Frick; J Dulak; J Dörler; R-H Zwick; W Dichtl; O Pachinger; F Weidinger
Journal:  Heart       Date:  2005-03       Impact factor: 5.994

2.  Factors determining heterogeneity in coronary collateral development: A clinical perspective.

Authors:  Pier D Lambiase; Michael S Marber
Journal:  Exp Clin Cardiol       Date:  2002

3.  Influence on collateral flow of recanalising chronic total coronary occlusions: a case-control study.

Authors:  T Pohl; P Hochstrasser; M Billinger; M Fleisch; B Meier; C Seiler
Journal:  Heart       Date:  2001-10       Impact factor: 5.994

4.  Circulating neuregulin-1β levels vary according to the angiographic severity of coronary artery disease and ischemia.

Authors:  Carrie Anna Geisberg; Guisong Wang; Radwan N Safa; Holly M Smith; Brent Anderson; Xu-Yang Peng; Brian Veerkamp; David X Zhao; Dana Blakemore; Chang Yu; Douglas B Sawyer
Journal:  Coron Artery Dis       Date:  2011-12       Impact factor: 1.439

Review 5.  Mechanistic, technical, and clinical perspectives in therapeutic stimulation of coronary collateral development by angiogenic growth factors.

Authors:  Gabor M Rubanyi
Journal:  Mol Ther       Date:  2013-02-12       Impact factor: 11.454

6.  Vascular endothelial growth factor genetic variability and coronary artery disease in Brazilian population.

Authors:  Patrícia Matos Biselli; Alexandre Rodrigues Guerzoni; Moacir Fernandes de Godoy; Erika Cristina Pavarino-Bertelli; Eny Maria Goloni-Bertollo
Journal:  Heart Vessels       Date:  2008-11-27       Impact factor: 2.037

7.  Angiogenesis, thrombogenesis, endothelial dysfunction and angiographic severity of coronary artery disease.

Authors:  N A Chung; C Lydakis; F Belgore; F L Li-Saw-Hee; A D Blann; G Y H Lip
Journal:  Heart       Date:  2003-12       Impact factor: 5.994

8.  Serum Sphingosine 1 Phosphate Levels in Patients with and without Coronary Collateral Circulation.

Authors:  Emrullah Kızıltunç; Murat Gök; Canan Topçuoğlu; Harun Kundi; Mustafa Çetin; Turan Turhan; Ender Örnek
Journal:  Acta Cardiol Sin       Date:  2018-09       Impact factor: 2.672

9.  Plasma chemokine levels are associated with the presence and extent of angiographic coronary collaterals in chronic ischemic heart disease.

Authors:  Ellen C Keeley; J Randall Moorman; Ling Liu; Lawrence W Gimple; Lewis C Lipson; Michael Ragosta; Angela M Taylor; Douglas E Lake; Marie D Burdick; Borna Mehrad; Robert M Strieter
Journal:  PLoS One       Date:  2011-06-22       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.